Literature DB >> 10924713

Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.

E Ros1.   

Abstract

Triglycerides and cholesterol are important biological lipids, and their excessive intake in the diet is relevant to the development of two prevalent cardiovascular risk factors, obesity and hypercholesterolemia. Because most lipids are essentially water-insoluble molecules, their transport within and absorption from the aqueous medium of intestinal contents is rather complex. This takes place in a series of orderly and interrelated steps, including emulsification, hydrolysis by specific esterases, micellar transport, mucosal absorption, re-synthesis of parent molecules in enterocytes, and assembly with apolipoproteins and other molecules to form chylomicrons, the secretory product of intestinal cells. Many of these processes, however, are not well characterized at the molecular level. While in health the intestinal absorption of triglycerides is very efficient, the same does not apply to cholesterol absorption. Besides being generally inefficient, cholesterol absorption is highly variable, with a between-subject variability that depends in part on genetic factors and an intra-individual variability, which may be modulated by physiological and dietary conditions. All of the sequential steps in intestinal lipid absorption can be interfered with by dietary components or drugs and thus are potential therapeutic targets for inducing a controlled malabsorption of triglyceride, useful in the treatment of obesity, or for rendering cholesterol absorption even more inefficient in an attempt to lower blood cholesterol levels. Nevertheless, intestinally derived cholesterol available to the liver exerts complex feedback regulation on whole-body cholesterol homeostasis that limits the efficacy of cholesterol absorption inhibitors to lower blood cholesterol. This review focuses first on present knowledge of the physiology of intestinal fat absorption, necessary to understand the ways to manipulate it in order to obtain the desired effects on dietary triglyceride and cholesterol disposition. The second part discusses old, present and future ways, both dietary and pharmacological. of interfering with cholesterol and triglyceride absorption to reduce blood cholesterol and energy acquisition, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924713     DOI: 10.1016/s0021-9150(00)00456-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  42 in total

Review 1.  Small bowel review: Normal physiology, part 1.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  Solubility in and affinity for the bile salt micelle of plant sterols are important determinants of their intestinal absorption in rats.

Authors:  Tadateru Hamada; Hitomi Goto; Takashi Yamahira; Takashi Sugawara; Katsumi Imaizumi; Ikuo Ikeda
Journal:  Lipids       Date:  2006-06       Impact factor: 1.880

3.  Anti-obesity activity of Yamabushitake (Hericium erinaceus) powder in ovariectomized mice, and its potentially active compounds.

Authors:  Eri Hiraki; Shoko Furuta; Rika Kuwahara; Naomichi Takemoto; Toshiro Nagata; Taiki Akasaka; Bungo Shirouchi; Masao Sato; Koichiro Ohnuki; Kuniyoshi Shimizu
Journal:  J Nat Med       Date:  2017-02-08       Impact factor: 2.343

4.  Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats.

Authors:  Megumi Matsumoto; Masashi Hosokawa; Noriko Matsukawa; Masahito Hagio; Aki Shinoki; Megumi Nishimukai; Kazuo Miyashita; Takaji Yajima; Hiroshi Hara
Journal:  Eur J Nutr       Date:  2009-11-04       Impact factor: 5.614

5.  Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine.

Authors:  Chang Xie 谢畅; Zhang-Sen Zhou 周章森; Na Li 李钠; Yan Bian 卞艳; Yong-Jian Wang 王永建; Li-Juan Wang 王丽娟; Bo-Liang Li 李伯良; Bao-Liang Song 宋保亮
Journal:  J Lipid Res       Date:  2012-07-17       Impact factor: 5.922

6.  Titanium Dioxide Nanoparticle Ingestion Alters Nutrient Absorption in an In Vitro Model of the Small Intestine.

Authors:  Zhongyuan Guo; Nicole J Martucci; Fabiola Moreno-Olivas; Elad Tako; Gretchen J Mahler
Journal:  NanoImpact       Date:  2017-01-18

7.  A comparison of the effect of medium- vs. long-chain triglycerides on the in vitro solubilization of cholesterol and/or phytosterol into mixed micelles.

Authors:  Anna von Bonsdorff-Nikander; Leena Christiansen; Laura Huikko; Anna-Maija Lampi; Vieno Piironen; Jouko Yliruusi; Ann Marie Kaukonen
Journal:  Lipids       Date:  2005-02       Impact factor: 1.880

8.  Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.

Authors:  M van Heek; C Farley; D S Compton; L Hoos; H R Davis
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

9.  Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells.

Authors:  Tomoko Konishi; Hideo Satsu; Yasuo Hatsugai; Koichi Aizawa; Takahiro Inakuma; Shinji Nagata; Sho-Hei Sakuda; Hiromichi Nagasawa; Makoto Shimizu
Journal:  Br J Pharmacol       Date:  2004-09-06       Impact factor: 8.739

10.  Lymphatic absorption and deposition of various plant sterols in stroke-prone spontaneously hypertensive rats, a strain having a mutation in ATP binding cassette transporter G5.

Authors:  Tadateru Hamada; Nami Egashira; Shoko Nishizono; Hiroko Tomoyori; Hideaki Nakagiri; Katsumi Imaizumi; Ikuo Ikeda
Journal:  Lipids       Date:  2007-01-23       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.